Paola Tacchetti

7PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomedicineHaematologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 14, 2025
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS.

Katia Mancuso, Marco Talarico, Enrica Manzato

|Nov 26, 2024
Clinical Presentation and Long-Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study.

K Mancuso, R Mina, S Rocchi

|Jul 27, 2024
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review.

Flavia Bigi, Enrica Manzato, Simona Barbato

|May 27, 2024
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma.

Paola Tacchetti, Marco Talarico, Simona Barbato

|Oct 05, 2022
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma.

Paola Tacchetti, Serena Rocchi, Elena Zamagni

|Jun 06, 2022
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.

Luca Bertamini, Stefania Oliva, Delia Rota-Scalabrini

Pageof 2

Frequent Collaborators

4 joint publications

Katia Mancuso

3 joint publications

Simona Barbato

3 joint publications

Ilaria Rizzello

3 joint publications

Elena Zamagni